Menu
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

AbbVie Inc.

WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Stock / Pharmaceuticals / Large Cap /

€195.00
1.670%

ABB Ltd. ADR

WKN: 675089 / Symbol: ABB / Name: ABB / Stock / Machinery, Equipment & Components / Large Cap /

€72.20
1.980%

Abbott Laboratories

WKN: 850103 / Symbol: ABT / Name: Abbott / Stock / Pharmaceuticals / Large Cap /

€94.84
0.920%

Abbisko Cayman Ltd.

WKN: A3C4Y0 / Name: Abbisko Cayman Ltd. / Stock / ? /

€1.31
-1.500%

Abbvie Inc.

WKN: A3DXS3 / Name: Abbvie Inc. / Stock / ? /

€17.90
-3.240%

Abb Ltd.

WKN: A40CMF / Name: Abb Ltd. / Stock / ? /

€7.20
2.130%

Abbott Laboratories

WKN: A417NR / Name: Abbott Laboratories / Stock / ? /

€12.00
0.840%

Abbvie Inc.

WKN: A2R76V / Name: Abbvie Inc. / Stock / ? /

€91.29
0.170%

Abbvie Inc.

WKN: A2R76U / Name: Abbvie Inc. / Stock / ? /

€97.26
0.040%

Abbott Ireland Financing Dac

WKN: A2SAR0 / Name: Abbott Ireland Financing Dac / Stock / ? /

€96.63
0.010%

Abbvie Inc.

WKN: A284E2 / Name: Abbvie Inc. / Stock / ? /

€100.43
0.070%

Abb Finance B.v.

WKN: A287Q8 / Name: Abb Finance B.v. / Stock / ? /

€90.26
0.030%

Abbvie Inc.

WKN: A284E1 / Name: Abbvie Inc. / Stock / ? /

€98.60
0.090%

Abbvie Inc.

WKN: A189FL / Name: Abbvie Inc. / Stock / ? /

€98.92
-0.010%

Abbott Ireland Financing Dac

WKN: A2RSC7 / Name: Abbott Ireland Financing Dac / Stock / ? /

€99.59
0.040%

Abb Finance B.v.

WKN: A3LCXN / Name: Abb Finance B.v. / Stock / ? /

€102.55
0.010%

AbbVie (ABBV) Tops Q4 Earnings and Revenue Estimates
AbbVie (ABBV) Tops Q4 Earnings and Revenue Estimates

AbbVie (ABBV) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.66 per share. This compares to earnings of $2.16 per share a year ago. These figures are

AbbVie (ABBV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
AbbVie (ABBV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, AbbVie (ABBV) reported revenue of $16.62 billion, up 10% over the same period last year. EPS came in at $2.71, compared to $2.16 in the year-ago quarter.

The

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the

Are Industrial Products Stocks Lagging  ABB (ABBNY) This Year?
Are Industrial Products Stocks Lagging ABB (ABBNY) This Year?

For those looking to find strong Industrial Products stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ABB (ABBNY) been one of those stocks this